This brand name is authorized in Austria, Brazil, Canada, Spain, France, Ireland
The drug MENJUGATE contains one active pharmaceutical ingredient (API):
|
1
Meningococcal group C conjugate vaccine
UNII ZT89E5A103 - NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07AH02 | Other meningococcal monovalent purified polysaccharides antigen | J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AH Meningococcal vaccines |
| J07AH07 | Meningococcus C, purified polysaccharides antigen conjugated | J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AH Meningococcal vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 510616060055507 |
| Country: CA | Health Products and Food Branch | Identifier(s): 02440709 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 79867 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 63301248 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
